Social Media on Prescription for Colorectal Cancer Patients
SMOP
SMOP - Social Media on Prescription, a Randomised Controlled Trial
1 other identifier
interventional
44
1 country
1
Brief Summary
The overall aim with this study is to get a deeper understanding of the potential benefits with a health platform for patients diagnosed with colorectal cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable colorectal-cancer
Started Dec 2018
Typical duration for not_applicable colorectal-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 30, 2018
CompletedFirst Posted
Study publicly available on registry
September 5, 2018
CompletedStudy Start
First participant enrolled
December 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
October 10, 2021
CompletedNovember 7, 2022
November 1, 2022
1.9 years
August 30, 2018
November 4, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Self empowerment measured by Cancer Behavior Inventory (CBI) scale
A 12-item measure of self-efficacy for coping with cancer that measures self empowerment and coping. Each question is answered on a 9 point Likert scale. The higher the score the more confident and self empowered
12 months
Secondary Outcomes (5)
Self empowerment measured by Cancer Behavior Inventory (CBI) scale
3 months
Compliance to treatment
12 months
Quality of life using a Likert scale question tested in several other studies
12 months
Usability of a health care platform
12 months
Generated Knowledge in Online Discussions
3 years
Study Arms (2)
Participation in the internet forum
EXPERIMENTALOther: Patients will be encouraged to participate in an internet forum communicating with other patients at least once per week. Participation in the internet forum
No participation in the internet forum
ACTIVE COMPARATOR"Placebo" Patients will not be able to enter or read in the forum, but will be able to read general information on the webpage where the forum is placed.
Interventions
Active participation in the forum with encouragement to participate on a weekly basis
No intervention performed. Patients are offered to read the open pages on the website
Eligibility Criteria
You may qualify if:
- Colorectal cancer diagnosis within 1 year
- Must be able to speak and read the Swedish language
- Must be able to use the health platform
You may not qualify if:
- Inability to speak and read the Swedish language
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sahlgrenska University Hospitallead
- Högskolan Västcollaborator
Study Sites (1)
Dept. of Surgery, Sahlgrenska University Hospital/Ostra
Gothenburg, SE 416 85, Sweden
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Martin Gellerstedt, Ph.D.
Högskolan Väst
- PRINCIPAL INVESTIGATOR
Eva Angenete, Ph.D., M.D.
Sahlgrenska University Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate professor, consultant surgeon
Study Record Dates
First Submitted
August 30, 2018
First Posted
September 5, 2018
Study Start
December 1, 2018
Primary Completion
October 31, 2020
Study Completion
October 10, 2021
Last Updated
November 7, 2022
Record last verified: 2022-11